This move is archived. Current quotes and coverage live on the stock page.
Follow BRY
Bri-Chem Corp. is facing a significant downturn in its stock performance, raising concerns among investors.
Bri-Chem Corp. (BRY.TO) is experiencing a sharp decline in its stock price, down 11.11% in today’s trading session. This drop brings the stock to a closing price of CA$0.32, reflecting ongoing challenges for the company amidst a turbulent market environment.
Advertisement
Bri-Chem Corp.
BRY.TO
BRY.TO
Bri-Chem Corp.
WealthAwesomeMarket cap
$6.87M
P/E
6.5x
52W high
$0.44
52W low
$0.20
1W change
-10.34%
Beta
-0.81
Analyst Price Targets
Based on analyst covering BRY · as of Sep 17, 2026
Wall Street analysts forecast BRY stock price to fall 15.4% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.22
-15.4% Upside
Current Price
C$0.26
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BRY's historical volatility
30-Day Vol
96.3%
Annualized
90-Day Vol
80.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.22
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.24 | C$0.18 – C$0.34 |
| 60 trading days | C$0.23 | C$0.14 – C$0.37 |
| 90 trading days | C$0.22 | C$0.12 – C$0.39 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should closely monitor Bri-Chem's performance and consider the implications of its recent financial results and market conditions before making any decisions.
Bri-Chem Corp. suffers a significant 11.11% drop in stock price today.
With a market cap of CA$9.5 million and a P/E ratio of 5.14, Bri-Chem's financial health is under scrutiny as it navigates this downturn.
Bull case
If Bri-Chem can effectively use its recent supply agreement with Reliant Technologies Inc. to improve its product offerings, it might regain some investor confidence over time.
Bear case
Recent financial results show declining sales and negative adjusted EBITDA, raising serious concerns about Bri-Chem's ability to operate effectively and maintain its market position.
Current Stock Performance
Advertisement
Bri-Chem Corp. has seen its stock price fall sharply by 11.11% in today’s trading session, closing at CA$0.32. This significant drop highlights the challenges the company faces, particularly in light of its recent financial performance.
Financial Health Concerns
The company's financial results have been troubling, with a reported decline in sales and negative adjusted EBITDA. Such metrics raise alarms about Bri-Chem's operational efficiency and ability to sustain investor interest moving forward.
Looking Ahead
While the recent supply agreement with Reliant Technologies Inc. could provide some strategic advantages, the overarching trend of declining sales and financial instability poses a significant risk for Bri-Chem. Investors should remain vigilant as they assess the company's future prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
